Search results
Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and...
WTNH-TV New Haven· 10 hours agoSyndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an...
Madrigal Pharmaceuticals Inc (MDGL) Shares Decline Despite Market Challenges – News Heater
NewsHeater· 14 hours agoMadrigal Pharmaceuticals Inc (NASDAQ: MDGL)’s stock price has gone decline by -7.48 in comparison to its previous close of 235.57, however, the company ...
Earnings call: Rhythm Pharmaceuticals sees steady IMCIVREE growth
Investing.com· 16 hours agoThe company has seen a consistent demand for the drug, with an increase in prescriptions and...
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 hours agoLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript May 7, 2024...
How does the drug abemaciclib treat breast cancer? - EconoTimes
EconoTimes· 10 hours agoThe anti-cancer drug abemaciclib (also known as Vernezio) has this month been added to the...
Teva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings
Barrons.com· 3 hours agoShares of Teva Pharmaceutical Industries were climbing yet again on Wednesday, after the company...
Drugmakers in Medicare negotiations spent more on shareholder payments and marketing than R&D last...
The Hill· 26 minutes agoA new report from the center-left watchdog group Accountable US found that most major drugmakers...
Marinus Pharmaceuticals (MRNS) Reports Q1 Loss, Lags Revenue Estimates
Zacks· 16 hours agoFree Report) came out with a quarterly loss of $0.68 per share in line with the Zacks Consensus Estimate. Over the last four quarters, the company has surpassed consensus ...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 5 hours agoRS Rating measures a stock's 12-month running performance against all other stocks. That RS Rating...
Madrigal sees ‘tremendous interest’ in NASH drug Rezdiffra
Seeking Alpha· 1 day agoMadrigal Pharmaceuticals (MDGL) reports encouraging initial uptake for its newly approved liver...